Our Stroke business delivers life-saving interventional solutions for patients with ischemic and hemorrhagic stroke for the best chance of a full recovery.
Accelerating the development of life-changing technologies to bring more care to more patients suffering from stroke and other devastating vascular diseases.
Imperative Care is addressing gaps across the entire patient journey — from detection through recovery — to elevate care for patients suffering from stroke and other devastating vascular diseases.
Our Stroke business delivers life-saving interventional solutions for patients with ischemic and hemorrhagic stroke for the best chance of a full recovery.
Our Vascular business (formerly TRUVIC Medical) advances innovative treatments for people suffering from devastating vascular diseases, including pulmonary embolism.
Kandu Health is a digital health company that delivers tech-enabled healthcare services to stroke survivors and care partners, supporting a safe and successful transition home after hospital discharge.
Telos Health is focused on developing advanced technologies to expand physicians’ ability to bring life-saving thrombectomies to more patients globally.
We know that the future is dependent on the innovations we invest in today.
Peter joined Imperative Care in 2023 bringing over 35 years of manufacturing, strategic supplier management and product development experience. Peter’s expertise is in the manufacturing efficiency and cost improvement derived from his experiences in operations management, outsource product development, and supplier management. Peter most recently held the position of Group VP and Chief Procurement Officer at Insulet Corporation. As a member of the Operations Leadership team Peter led Insulet’s contract manufacturing of insulin pumps and the Irvine manufacturing site specializing in nitinol wire assembly manufacturing. He led efforts to optimize contract manufacturing performance in China and develop strategy to expand Insulet’s manufacturing footprint to Malaysia. Prior to Insulet, Peter was the global leader of contract manufacturing at Harman International managing their entire automotive contract manufacturing engagements. Peter’s experience also includes leadership roles at Navico Corp and Bose Corp. Peter has a Bachelor of Science in Management (Industrial) Engineering from Worcester Polytechnic Institute and an MBA from the F.W. Olin School of Business at Babson College.
Henrietta Fore
Holsman International
Andrew Hack, M.D., Ph.D.
Bain Capital
John J. Hamre, Ph.D.
Center for Strategic International Studies
L. Nelson (Nick) Hopkins,
M.D. F.A.C.S.
University of Buffalo
Fred Khosravi
Imperative Care
Shacey Petrovic, Vice Chair
Insulet Corporation
Hank Plain
Lightstone Ventures
James Rogers
D1 Capital Partners L.P
Amarpreet (Amar) Sawhney, Ph.D.
Incept, LLC
Stacy Enxing Seng
Lightstone Venture
Holly Sheffield
CooperSurgical
Frank Yu
Ally Bridge Group
From day one, Imperative Care has prioritized clinical insights and collaboration with clinicians to inform our approach to elevating stroke care. Our founding clinical advisors have been involved with the company since its inception, and continually help advise on the company’s product pipeline and clinical strategy. The three founding clinical advisors are Adnan Siddiqui, M.D., Ph.D., Neurosurgeon at the University of Buffalo Neurosurgery; Aquilla “Quill” Turk, D.O., Neuroendovascular surgeon in Greenville Health System; and J Mocco, M.D., M.S. Neurosurgeon at the Mount Sinai Health System, New York. All founding clinical advisors are stockholders in Imperative Care.